Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Impact of Tamsulosin on Voiding Patterns Following Early Catheter Removal After Robot-assisted Laparoscopic Radical Prostatectomy

NCT01209988 · Asan Medical Center · Updated 28 Sept 2010

What is being tested
tamsulosin 0.4mg; No medication
For
Prostatic Neoplasms, Prostatectomy
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages Not stated. About 220 people. The full rules are on the registry page.
Where
South Korea
When
Starts or started April 2010, ends Dec 2011. Registered 28 Sept 2010.
Results
None posted yet.

In the researchers' words

To date, there is a lack of consensus concerning the optimal timing for removal of the urethral catheter, its related complications, the effectiveness in prophylactic drug use to reduce complication, and the patient reported outcomes (quality of life) after robot-assisted laparoscopic prostatectomy (RALP). The purpose of this study is to determine the impact of tamsulosin on voiding patterns following early urethral catheter removal after RALP for prostate cancer.
ClinicalTrials.gov, NCT01209988

Sites

  • Asan Medical CenterSeoul, South Korea